These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 35843134)
1. Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis. Hohenfellner K; Nießl C; Haffner D; Oh J; Okorn C; Palm K; Schlingmann KP; Wygoda S; Gahl WA Mol Genet Metab; 2022 Aug; 136(4):282-288. PubMed ID: 35843134 [TBL] [Abstract][Full Text] [Related]
2. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy. Nesterova G; Williams C; Bernardini I; Gahl WA Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929 [TBL] [Abstract][Full Text] [Related]
3. Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis. Nießl C; Boulesteix AL; Oh J; Palm K; Schlingmann P; Wygoda S; Haffner D; Wühl E; Tönshoff B; Buescher A; Billing H; Hoppe B; Zirngibl M; Kettwig M; Moeller K; Acham-Roschitz B; Arbeiter K; Bald M; Benz M; Galiano M; John-Kroegel U; Klaus G; Marx-Berger D; Moser K; Mueller D; Patzer L; Pohl M; Seitz B; Treikauskas U; von Vigier RO; Gahl WA; Hohenfellner K Mol Genet Metab; 2022 Aug; 136(4):268-273. PubMed ID: 35835062 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment of nephropathic cystinosis with cysteamine. Kleta R; Gahl WA Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372 [TBL] [Abstract][Full Text] [Related]
5. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study. Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148 [TBL] [Abstract][Full Text] [Related]
11. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN; Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776 [TBL] [Abstract][Full Text] [Related]
12. NIH conference. Cystinosis: progress in a prototypic disease. Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161 [TBL] [Abstract][Full Text] [Related]
13. Parenchymal organ cystine depletion with long-term cysteamine therapy. Gahl WA; Charnas L; Markello TC; Bernardini I; Ishak KG; Dalakas MC Biochem Med Metab Biol; 1992 Dec; 48(3):275-85. PubMed ID: 1476793 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report. Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840 [TBL] [Abstract][Full Text] [Related]
15. Follow-up and treatment of adults with cystinosis in the Netherlands. Geelen JM; Monnens LA; Levtchenko EN Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982 [TBL] [Abstract][Full Text] [Related]
16. Extrarenal complications of cystinosis. Topaloglu R Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152 [TBL] [Abstract][Full Text] [Related]
17. Effects of long-term cysteamine treatment in patients with cystinosis. Ariceta G; Giordano V; Santos F Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317 [TBL] [Abstract][Full Text] [Related]